valaciclovir 500mg tablets
ranbaxy (uk) ltd - valaciclovir hydrochloride - oral tablet - 500mg
valaciclovir 500mg tablets
waymade healthcare plc - valaciclovir hydrochloride - oral tablet - 500mg
valaciclovir 500mg tablets
aptil pharma ltd - valaciclovir hydrochloride - oral tablet - 500mg
valaciclovir 500mg tablets
mawdsley-brooks & company ltd - valaciclovir hydrochloride - oral tablet - 500mg
valaciclovir 500mg tablets
milpharm ltd - valaciclovir hydrochloride - oral tablet - 500mg
apo-valaciclovir
apotex pty ltd - valaciclovir hydrochloride monohydrate -
valaciclovir-str valaciclovir 1000 mg (as hydrochloride) tablet blister pack
gm pharma international pty ltd - valaciclovir hydrochloride, quantity: 1112 mg (equivalent: valaciclovir, qty 1000 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; crospovidone; povidone; magnesium stearate; colloidal anhydrous silica; carnauba wax; colour - for the treatment of herpes zoster (shingles) in adult patients who commence therapy within 72 hours of the onset of rash. for the treatment of ophthalmic zoster. for the treatment of recurrent herpes labialis (cold sores) for the treatment of clinical episodes of genital herpes simplex infections. for the prevention of recurrent genital herpes. reduction of transmission of genital herpes in patients suffering from recurrent genital herpes. in addition to therapy with valtrex, it is recommended that patients use safer sex practices. (see precautions). prophylaxis of cytomegalovirus (cmv) infection and disease following solid organ transplantation in patients at risk of cmv disease.
valaciclovir-str valaciclovir 500 mg (as hydrochloride) tablet blister pack
gm pharma international pty ltd - valaciclovir hydrochloride, quantity: 556 mg (equivalent: valaciclovir, qty 500 mg) - tablet, film coated - excipient ingredients: povidone; crospovidone; colloidal anhydrous silica; carnauba wax; magnesium stearate; microcrystalline cellulose; colour - for the treatment of herpes zoster (shingles) in adult patients who commence therapy within 72 hours of the onset of rash. for the treatment of ophthalmic zoster. for the treatment of recurrent herpes labialis (cold sores) for the treatment of clinical episodes of genital herpes simplex infections. for the prevention of recurrent genital herpes. reduction of transmission of genital herpes in patients suffering from recurrent genital herpes. in addition to therapy with valtrex, it is recommended that patients use safer sex practices. (see precautions). prophylaxis of cytomegalovirus (cmv) infection and disease following solid organ transplantation in patients at risk of cmv disease.
valaciclovir-str valaciclovir 500 mg (as hydrochloride) tablet bottle
gm pharma international pty ltd - valaciclovir hydrochloride, quantity: 556 mg (equivalent: valaciclovir, qty 500 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; crospovidone; povidone; magnesium stearate; colloidal anhydrous silica; carnauba wax; colour - for the treatment of herpes zoster (shingles) in adult patients who commence therapy within 72 hours of the onset of rash. for the treatment of ophthalmic zoster. for the treatment of recurrent herpes labialis (cold sores) for the treatment of clinical episodes of genital herpes simplex infections. for the prevention of recurrent genital herpes. reduction of transmission of genital herpes in patients suffering from recurrent genital herpes. in addition to therapy with valtrex, it is recommended that patients use safer sex practices. (see precautions). prophylaxis of cytomegalovirus (cmv) infection and disease following solid organ transplantation in patients at risk of cmv disease.
valaciclovir-arx valaciclovir 1000 mg (as hydrochloride) tablet blister pack
arrotex pharmaceuticals pty ltd - valaciclovir hydrochloride, quantity: 1112 mg (equivalent: valaciclovir, qty 1000 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; crospovidone; povidone; magnesium stearate; colloidal anhydrous silica; carnauba wax; colour - for the treatment of herpes zoster (shingles) in adult patients who commence therapy within 72 hours of the onset of rash. for the treatment of ophthalmic zoster. for the treatment of recurrent herpes labialis (cold sores) for the treatment of clinical episodes of genital herpes simplex infections. for the prevention of recurrent genital herpes. reduction of transmission of genital herpes in patients suffering from recurrent genital herpes. in addition to therapy with valtrex, it is recommended that patients use safer sex practices. (see precautions). prophylaxis of cytomegalovirus (cmv) infection and disease following solid organ transplantation in patients at risk of cmv disease.